Upcoming event
Masterclass on Non-muscle-invasive bladder cancer
Back

Tag: AUA21

Microhematuria in women: Prevalence of malignancy and risk score evaluation

Phase III Trial of Intravesical Nadofaragene Firadenovec in Patients with High-Grade, BCG-Unresponsive, Non-muscle Invasive Bladder Cancer: Two Year Follow-up in the Ta/T1 Cohort

Pathological features and clinical behavior of Lynch syndrome-associated bladder cancer

Biomarkers of Exposure Associated with Bladder Cancer Risk Produced by Heat-Not-Burn Devices Compared to Combustible Cigarettes